TCL Archive Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million. December 9, 2005
TCL Archive In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts” March 26, 1976
TCL Archive FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’ January 31, 1992
